In conclusion, this study systematically demonstrates, for the first time, that curcumol can reverse sorafenib resistance in HCC by modulating the PI3K/AKT and JAK/STAT signaling pathways. This evidence concerns the gene AKT1 and hepatocellular carcinoma.